Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Clovis Oncology Inc (CLVSQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Clovis historical data, for real-time data please try another search
0.016 +0.000    +0.00%
10/07 - Delayed Data. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.010 - 0.017
Type:  Equity
Market:  United States
Clovis 0.016 +0.000 +0.00%

Clovis Option Chain and Prices

 
CLVSQ option chain data. View the call and put strike options, last price, change, volume and implied volatility for Clovis. Quotes and Analysis tables are both available to toggle between.

Align your trading plan by setting your own filters such as Clovis Options expiration date, calls or puts (or both), and strike price.
Expiration Date:
Show:
Strike Price:
Dec 21, 2022 16:21 GMT

Calls

Puts

Last Chg. Bid Ask Vol Strike Last Chg. Bid Ask Vol
0.081
Price @ Dec 21, 2022 16:21 GMT
0.05 0% 0.03 0.08 0 0.50 0.43 0% 0.4 0.45 0
0.05 0% 0.01 0.08 0 1.00 0.75 0% 0.32 1 0
0.03 0% 0.03 0.14 0 1.50 1.43 0% 0.02 1.48 0

Open Positions

 Calls
 Puts
© 2016 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CLVSQ Price Commentary

Write your thoughts about Clovis Oncology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Svetljo Svetljo
Svetljo Svetljo Nov 22, 2022 20:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news ?
Arminvest Net
Arminvest Net Jul 05, 2022 12:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
33 soon
John Rollings
John Rollings Apr 20, 2022 14:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A company does not host a webcast to announce poor financial results ! They only do that when the results are really good ! This is gonna SHOOT RIGHT UP !
John Rollings
John Rollings Apr 20, 2022 14:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A company does not host a webcast to announce poor financial results ! They only do that when the results are really good ! This is gonna *****!
John Rollings
John Rollings Apr 20, 2022 14:44
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4 4/20/2022 BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its rst quarter 2022 nancial results on Wednesday, May 4, 2022, before the open of the US nancial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss the Company’s results in greater detail. The conference call will be simultaneously webcast on the Clovis Oncology website www.clovisoncology.com, and a replay of the webcast will be available for 30 days. Dial-in numbers for the conference call are as follows: US participants 888.440.4615, International participants 646.960.0682, conference ID: 2259685
John Rollings
John Rollings Apr 11, 2022 19:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
NOT LONG BEFORE PFIZER OR A SIMILAR BIG PHARMA SNAPS THIS UP AND SHARES WORTH 10 X WHAT THEY ARE NOW AT $2.48 IN MY OPINION DYOR Clovis Oncology’s Rubraca® (Rucaparib) Signicantly Improves Progression-Free Survival in First-line Maintenance Treatment in Women with Ovarian Cancer Regardless of Their Biomarker Status in Phase 3 ATHENA-MONO Trial 3/31/2022 https://s22.q4cdn.com/778348918/files/doc_news/Clovis-Oncologys-Rubraca-Rucaparib-Significantly-Improves-Progression-Free-Survival-in-First-line-Maintenance-Treatment-in-Women-with-C16N4.pdf
Co Co
Co Co Mar 24, 2021 21:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Clvs might be next gme apparently
Co Co
Co Co Mar 19, 2021 13:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Shouldnt be to quiet today
L X Apurbo Vai
L X Apurbo Vai Mar 19, 2021 13:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what
Co Co
Co Co Mar 19, 2021 13:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sorry my reply to an old comment
Peter Gowler
Peter Gowler Feb 26, 2021 14:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
quite in here lol
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email